Here, we show that 2%, i.e., 6 out of 368 bladder patients, showed O6-methylguanine-DNA methylftransferase (MGMT) promoter hypermethylation which is in line with previous reports [53–55]. Here, MGMT is linked to urogenital neoplasm.